Elicitation of Rheumatologist Preferences for the Treatment of Patients with Rheumatoid Arthritis After the Failure of a First Conventional Synthetic Disease-Modifying Anti-Rheumatic Agent
posted on 2021-04-29, 17:36authored byAdis Journals on behalf of, Eric Senbel, Frederick Durand, Baptiste Roux, Fatima-Zohra Badaoui, Bruno Fautrel
Article full
text
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).